Contrast Injector Systems Market to Reach $1.5 Bn, Globally, by 2030 at 7.3% CAGR: Allied Market Research
22 Jun 2022
Vaccine
Increase in number of angiography, CT and MRI procedures, growth in technological sophistication, and surge in chronic diseases drive the growth of the global contrast injector systems market.
PORTLAND, Ore., June 22, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Contrast Injector Systems Market
by Product Type (Consumables, Injector Systems, Accessories), by Application (Radiology, Interventional Radiology, Interventional Cardiology), by End User (Hospitals, Diagnostics centers, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030". According to the report, the global contrast injector systems industry generated $755.57 billion in 2020, and is anticipated to generate $1.5 billion by 2030, witnessing a CAGR of 7.3% from 2021 to 2030.
Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/3977
Prime determinants of growth
Increase in number of angiography, CT, and MRI procedures, growth in technological sophistication, and surge in chronic diseases drive the growth of the global contrast injector systems market. However, high cost and risk associated with contrast injector systems and contrast media hinder the market growth. On the other hand, rise in healthcare expenditure and emergence of complex diseases in developing countries present new opportunities in the coming years.
Covid-19 Scenario
The outbreak of the COVID-19 pandemic has had a negative impact on the growth of the global contrast injector systems market, owing to decline in number of geriatric patient visits in hospitals and clinics.
Also, during the global lockdown, number of patients coming for CT & MRI declined in order to maintain the social distancing norms. This hampered the market growth.
However, the market is going to recover soon in 2022.
The radiology
segment to maintain its leadership status throughout the forecast period
Based on application, the radiology segment held the highest market share in 2020, accounting for nearly two-fifths of the global contrast injector systems market, and is estimated to maintain its leadership status throughout the forecast period. This is owing to surging occurrences of chronic disorders among the growing population, increase in the aging population, and changes in societal behavior. However, the interventional radiology segment is projected to manifest the highest CAGR of 8.4% from 2021 to 2030, owing to reduced risks, lower cost, higher level of comfort, shorter hospital stays, and quicker recovery.
Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/3977
The hospitals segment to maintain its lead position during the forecast period
Based on end user, the hospitals segment accounted for the largest share in 2020, contributing to around one-third of the global contrast injector systems market, and is projected to maintain its lead position during the forecast period. This is owing to large number of patient visits to the hospitals for diagnosis than clinics. However, the diagnostic centers segment is expected to portray the largest CAGR of 7.9% from 2021 to 2030, owing to onset of complex diseases among the population base that has necessitated the need for detailed examination and early diagnosis pattern of diseases.
North America to maintain its dominance by 2030
Based on region, North America held the highest market share in terms of revenue 2020, accounting for more than two-fifths of the global contrast injector systems market, owing to the well-established healthcare facilities, recent technological advancements, and rise in demand for early diagnosis of chronic diseases due to increase in awareness regarding contrast injectors. However, the Asia-Pacific region is expected to witness the fastest CAGR of 8.1% during the forecast period, owing to increase in incidence of various chronic diseases such as cancer, heart diseases, Alzheimer's, and dementia.
Leading Market Players
Bracco Imaging S.p.A
Ulrich GmbH & Co. KG
Shenzhen Seacrown Electromechanical Co., Ltd.
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
3D Printing Healthcare Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
Ultrasound Devices Market - Global Opportunity Analysis and Industry Forecast, 2020-2028
Remote Patient Monitoring Market - Global Opportunity Analysis and Industry Forecast, 2020-2028
Vaccines Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
Hepatitis Therapeutics Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
India Disposable Syringes Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
Urinary Incontinence Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
Cold Plasma Implant Treatment Devices Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
Medical Cannabis Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
Plant Tissue Culture Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/
Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
SOURCE Allied Market Research
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.